Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Virus Vector Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Retroviral Vectors
1.2.3 Adenoviral Vectors
1.2.4 Adeno-Associated Viral Vectors
1.2.5 Other
1.3 Market by Application
1.3.1 Global Genetic Virus Vector Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Genetic Virus Vector Market Perspective (2016-2027)
2.2 Genetic Virus Vector Growth Trends by Regions
2.2.1 Genetic Virus Vector Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genetic Virus Vector Historic Market Share by Regions (2016-2021)
2.2.3 Genetic Virus Vector Forecasted Market Size by Regions (2022-2027)
2.3 Genetic Virus Vector Industry Dynamic
2.3.1 Genetic Virus Vector Market Trends
2.3.2 Genetic Virus Vector Market Drivers
2.3.3 Genetic Virus Vector Market Challenges
2.3.4 Genetic Virus Vector Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Genetic Virus Vector Players by Revenue
3.1.1 Global Top Genetic Virus Vector Players by Revenue (2016-2021)
3.1.2 Global Genetic Virus Vector Revenue Market Share by Players (2016-2021)
3.2 Global Genetic Virus Vector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genetic Virus Vector Revenue
3.4 Global Genetic Virus Vector Market Concentration Ratio
3.4.1 Global Genetic Virus Vector Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Virus Vector Revenue in 2020
3.5 Genetic Virus Vector Key Players Head office and Area Served
3.6 Key Players Genetic Virus Vector Product Solution and Service
3.7 Date of Enter into Genetic Virus Vector Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Virus Vector Breakdown Data by Type
4.1 Global Genetic Virus Vector Historic Market Size by Type (2016-2021)
4.2 Global Genetic Virus Vector Forecasted Market Size by Type (2022-2027)

5 Genetic Virus Vector Breakdown Data by Application
5.1 Global Genetic Virus Vector Historic Market Size by Application (2016-2021)
5.2 Global Genetic Virus Vector Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Genetic Virus Vector Market Size (2016-2027)
6.2 North America Genetic Virus Vector Market Size by Type
6.2.1 North America Genetic Virus Vector Market Size by Type (2016-2021)
6.2.2 North America Genetic Virus Vector Market Size by Type (2022-2027)
6.2.3 North America Genetic Virus Vector Market Size by Type (2016-2027)
6.3 North America Genetic Virus Vector Market Size by Application
6.3.1 North America Genetic Virus Vector Market Size by Application (2016-2021)
6.3.2 North America Genetic Virus Vector Market Size by Application (2022-2027)
6.3.3 North America Genetic Virus Vector Market Size by Application (2016-2027)
6.4 North America Genetic Virus Vector Market Size by Country
6.4.1 North America Genetic Virus Vector Market Size by Country (2016-2021)
6.4.2 North America Genetic Virus Vector Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Genetic Virus Vector Market Size (2016-2027)
7.2 Europe Genetic Virus Vector Market Size by Type
7.2.1 Europe Genetic Virus Vector Market Size by Type (2016-2021)
7.2.2 Europe Genetic Virus Vector Market Size by Type (2022-2027)
7.2.3 Europe Genetic Virus Vector Market Size by Type (2016-2027)
7.3 Europe Genetic Virus Vector Market Size by Application
7.3.1 Europe Genetic Virus Vector Market Size by Application (2016-2021)
7.3.2 Europe Genetic Virus Vector Market Size by Application (2022-2027)
7.3.3 Europe Genetic Virus Vector Market Size by Application (2016-2027)
7.4 Europe Genetic Virus Vector Market Size by Country
7.4.1 Europe Genetic Virus Vector Market Size by Country (2016-2021)
7.4.2 Europe Genetic Virus Vector Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Genetic Virus Vector Market Size (2016-2027)
8.2 Asia-Pacific Genetic Virus Vector Market Size by Type
8.2.1 Asia-Pacific Genetic Virus Vector Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genetic Virus Vector Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genetic Virus Vector Market Size by Type (2016-2027)
8.3 Asia-Pacific Genetic Virus Vector Market Size by Application
8.3.1 Asia-Pacific Genetic Virus Vector Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genetic Virus Vector Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genetic Virus Vector Market Size by Application (2016-2027)
8.4 Asia-Pacific Genetic Virus Vector Market Size by Region
8.4.1 Asia-Pacific Genetic Virus Vector Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genetic Virus Vector Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Genetic Virus Vector Market Size (2016-2027)
9.2 Latin America Genetic Virus Vector Market Size by Type
9.2.1 Latin America Genetic Virus Vector Market Size by Type (2016-2021)
9.2.2 Latin America Genetic Virus Vector Market Size by Type (2022-2027)
9.2.3 Latin America Genetic Virus Vector Market Size by Type (2016-2027)
9.3 Latin America Genetic Virus Vector Market Size by Application
9.3.1 Latin America Genetic Virus Vector Market Size by Application (2016-2021)
9.3.2 Latin America Genetic Virus Vector Market Size by Application (2022-2027)
9.3.3 Latin America Genetic Virus Vector Market Size by Application (2016-2027)
9.4 Latin America Genetic Virus Vector Market Size by Country
9.4.1 Latin America Genetic Virus Vector Market Size by Country (2016-2021)
9.4.2 Latin America Genetic Virus Vector Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Genetic Virus Vector Market Size (2016-2027)
10.2 Middle East & Africa Genetic Virus Vector Market Size by Type
10.2.1 Middle East & Africa Genetic Virus Vector Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genetic Virus Vector Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genetic Virus Vector Market Size by Type (2016-2027)
10.3 Middle East & Africa Genetic Virus Vector Market Size by Application
10.3.1 Middle East & Africa Genetic Virus Vector Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genetic Virus Vector Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genetic Virus Vector Market Size by Application (2016-2027)
10.4 Middle East & Africa Genetic Virus Vector Market Size by Country
10.4.1 Middle East & Africa Genetic Virus Vector Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genetic Virus Vector Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 FUJIFILM Diosynth Biotechnologies U.S.A.
11.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Company Details
11.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview
11.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Introduction
11.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2016-2021)
11.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Genetic Virus Vector Introduction
11.2.4 Sanofi Revenue in Genetic Virus Vector Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Genetic Virus Vector Introduction
11.3.4 Lonza Revenue in Genetic Virus Vector Business (2016-2021)
11.3.5 Lonza Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Genetic Virus Vector Introduction
11.4.4 Merck KGaA Revenue in Genetic Virus Vector Business (2016-2021)
11.4.5 Merck KGaA Recent Development
11.5 GENERAL ELECTRIC COMPANY
11.5.1 GENERAL ELECTRIC COMPANY Company Details
11.5.2 GENERAL ELECTRIC COMPANY Business Overview
11.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Introduction
11.5.4 GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2016-2021)
11.5.5 GENERAL ELECTRIC COMPANY Recent Development
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Details
11.6.2 Oxford BioMedica Business Overview
11.6.3 Oxford BioMedica Genetic Virus Vector Introduction
11.6.4 Oxford BioMedica Revenue in Genetic Virus Vector Business (2016-2021)
11.6.5 Oxford BioMedica Recent Development
11.7 Spark Therapeutics, Inc.
11.7.1 Spark Therapeutics, Inc. Company Details
11.7.2 Spark Therapeutics, Inc. Business Overview
11.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Introduction
11.7.4 Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2016-2021)
11.7.5 Spark Therapeutics, Inc. Recent Development
11.8 uniQure N.V.
11.8.1 uniQure N.V. Company Details
11.8.2 uniQure N.V. Business Overview
11.8.3 uniQure N.V. Genetic Virus Vector Introduction
11.8.4 uniQure N.V. Revenue in Genetic Virus Vector Business (2016-2021)
11.8.5 uniQure N.V. Recent Development
11.9 FinVector Vision Therapies
11.9.1 FinVector Vision Therapies Company Details
11.9.2 FinVector Vision Therapies Business Overview
11.9.3 FinVector Vision Therapies Genetic Virus Vector Introduction
11.9.4 FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2016-2021)
11.9.5 FinVector Vision Therapies Recent Development
11.10 Brammer Bio
11.10.1 Brammer Bio Company Details
11.10.2 Brammer Bio Business Overview
11.10.3 Brammer Bio Genetic Virus Vector Introduction
11.10.4 Brammer Bio Revenue in Genetic Virus Vector Business (2016-2021)
11.10.5 Brammer Bio Recent Development
11.11 Cell and Gene Therapy Catapult
11.11.1 Cell and Gene Therapy Catapult Company Details
11.11.2 Cell and Gene Therapy Catapult Business Overview
11.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Introduction
11.11.4 Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2016-2021)
11.11.5 Cell and Gene Therapy Catapult Recent Development
11.12 Cobra Biologics
11.12.1 Cobra Biologics Company Details
11.12.2 Cobra Biologics Business Overview
11.12.3 Cobra Biologics Genetic Virus Vector Introduction
11.12.4 Cobra Biologics Revenue in Genetic Virus Vector Business (2016-2021)
11.12.5 Cobra Biologics Recent Development
11.13 REGENXBIO Inc.
11.13.1 REGENXBIO Inc. Company Details
11.13.2 REGENXBIO Inc. Business Overview
11.13.3 REGENXBIO Inc. Genetic Virus Vector Introduction
11.13.4 REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2016-2021)
11.13.5 REGENXBIO Inc. Recent Development
11.14 Kaneka Eurogentec S.A.
11.14.1 Kaneka Eurogentec S.A. Company Details
11.14.2 Kaneka Eurogentec S.A. Business Overview
11.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Introduction
11.14.4 Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2016-2021)
11.14.5 Kaneka Eurogentec S.A. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Genetic Virus Vector Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Retroviral Vectors
Table 3. Key Players of Adenoviral Vectors
Table 4. Key Players of Adeno-Associated Viral Vectors
Table 5. Key Players of Other
Table 6. Global Genetic Virus Vector Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Genetic Virus Vector Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Genetic Virus Vector Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Genetic Virus Vector Market Share by Regions (2016-2021)
Table 10. Global Genetic Virus Vector Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Genetic Virus Vector Market Share by Regions (2022-2027)
Table 12. Genetic Virus Vector Market Trends
Table 13. Genetic Virus Vector Market Drivers
Table 14. Genetic Virus Vector Market Challenges
Table 15. Genetic Virus Vector Market Restraints
Table 16. Global Genetic Virus Vector Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Genetic Virus Vector Market Share by Players (2016-2021)
Table 18. Global Top Genetic Virus Vector Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Virus Vector as of 2020)
Table 19. Ranking of Global Top Genetic Virus Vector Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Genetic Virus Vector Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genetic Virus Vector Product Solution and Service
Table 23. Date of Enter into Genetic Virus Vector Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genetic Virus Vector Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Genetic Virus Vector Revenue Market Share by Type (2016-2021)
Table 27. Global Genetic Virus Vector Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Genetic Virus Vector Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Genetic Virus Vector Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Genetic Virus Vector Revenue Market Share by Application (2016-2021)
Table 31. Global Genetic Virus Vector Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Genetic Virus Vector Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Genetic Virus Vector Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Genetic Virus Vector Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Genetic Virus Vector Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Genetic Virus Vector Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Genetic Virus Vector Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Genetic Virus Vector Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Genetic Virus Vector Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Genetic Virus Vector Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Genetic Virus Vector Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Genetic Virus Vector Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Genetic Virus Vector Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Genetic Virus Vector Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Genetic Virus Vector Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Genetic Virus Vector Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Genetic Virus Vector Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Genetic Virus Vector Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Genetic Virus Vector Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Genetic Virus Vector Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Genetic Virus Vector Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Genetic Virus Vector Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Genetic Virus Vector Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Genetic Virus Vector Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Genetic Virus Vector Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Genetic Virus Vector Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Genetic Virus Vector Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Genetic Virus Vector Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Genetic Virus Vector Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Genetic Virus Vector Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Genetic Virus Vector Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Genetic Virus Vector Market Size by Country (2022-2027) & (US$ Million)
Table 63. FUJIFILM Diosynth Biotechnologies U.S.A. Company Details
Table 64. FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview
Table 65. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product
Table 66. FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 67. FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Genetic Virus Vector Product
Table 71. Sanofi Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Lonza Company Details
Table 74. Lonza Business Overview
Table 75. Lonza Genetic Virus Vector Product
Table 76. Lonza Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 77. Lonza Recent Development
Table 78. Merck KGaA Company Details
Table 79. Merck KGaA Business Overview
Table 80. Merck KGaA Genetic Virus Vector Product
Table 81. Merck KGaA Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 82. Merck KGaA Recent Development
Table 83. GENERAL ELECTRIC COMPANY Company Details
Table 84. GENERAL ELECTRIC COMPANY Business Overview
Table 85. GENERAL ELECTRIC COMPANY Genetic Virus Vector Product
Table 86. GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 87. GENERAL ELECTRIC COMPANY Recent Development
Table 88. Oxford BioMedica Company Details
Table 89. Oxford BioMedica Business Overview
Table 90. Oxford BioMedica Genetic Virus Vector Product
Table 91. Oxford BioMedica Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 92. Oxford BioMedica Recent Development
Table 93. Spark Therapeutics, Inc. Company Details
Table 94. Spark Therapeutics, Inc. Business Overview
Table 95. Spark Therapeutics, Inc. Genetic Virus Vector Product
Table 96. Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 97. Spark Therapeutics, Inc. Recent Development
Table 98. uniQure N.V. Company Details
Table 99. uniQure N.V. Business Overview
Table 100. uniQure N.V. Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 101. uniQure N.V. Recent Development
Table 102. FinVector Vision Therapies Company Details
Table 103. FinVector Vision Therapies Business Overview
Table 104. FinVector Vision Therapies Genetic Virus Vector Product
Table 105. FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 106. FinVector Vision Therapies Recent Development
Table 107. Brammer Bio Company Details
Table 108. Brammer Bio Business Overview
Table 109. Brammer Bio Genetic Virus Vector Product
Table 110. Brammer Bio Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 111. Brammer Bio Recent Development
Table 112. Cell and Gene Therapy Catapult Company Details
Table 113. Cell and Gene Therapy Catapult Business Overview
Table 114. Cell and Gene Therapy Catapult Genetic Virus Vector Product
Table 115. Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 116. Cell and Gene Therapy Catapult Recent Development
Table 117. Cobra Biologics Company Details
Table 118. Cobra Biologics Business Overview
Table 119. Cobra Biologics Genetic Virus Vector Product
Table 120. Cobra Biologics Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 121. Cobra Biologics Recent Development
Table 122. REGENXBIO Inc. Company Details
Table 123. REGENXBIO Inc. Business Overview
Table 124. REGENXBIO Inc. Genetic Virus Vector Product
Table 125. REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 126. REGENXBIO Inc. Recent Development
Table 127. Kaneka Eurogentec S.A. Company Details
Table 128. Kaneka Eurogentec S.A. Business Overview
Table 129. Kaneka Eurogentec S.A. Genetic Virus Vector Product
Table 130. Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2016-2021) & (US$ Million)
Table 131. Kaneka Eurogentec S.A. Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Virus Vector Market Share by Type: 2020 VS 2027
Figure 2. Retroviral Vectors Features
Figure 3. Adenoviral Vectors Features
Figure 4. Adeno-Associated Viral Vectors Features
Figure 5. Other Features
Figure 6. Global Genetic Virus Vector Market Share by Application: 2020 VS 2027
Figure 7. Gene Therapy Case Studies
Figure 8. Vaccinology Case Studies
Figure 9. Genetic Virus Vector Report Years Considered
Figure 10. Global Genetic Virus Vector Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Genetic Virus Vector Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Genetic Virus Vector Market Share by Regions: 2020 VS 2027
Figure 13. Global Genetic Virus Vector Market Share by Regions (2022-2027)
Figure 14. Global Genetic Virus Vector Market Share by Players in 2020
Figure 15. Global Top Genetic Virus Vector Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Virus Vector as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Genetic Virus Vector Revenue in 2020
Figure 17. Global Genetic Virus Vector Revenue Market Share by Type (2016-2021)
Figure 18. Global Genetic Virus Vector Revenue Market Share by Type (2022-2027)
Figure 19. North America Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Genetic Virus Vector Market Share by Type (2016-2027)
Figure 21. North America Genetic Virus Vector Market Share by Application (2016-2027)
Figure 22. North America Genetic Virus Vector Market Share by Country (2016-2027)
Figure 23. United States Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Genetic Virus Vector Market Share by Type (2016-2027)
Figure 27. Europe Genetic Virus Vector Market Share by Application (2016-2027)
Figure 28. Europe Genetic Virus Vector Market Share by Country (2016-2027)
Figure 29. Germany Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Genetic Virus Vector Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Genetic Virus Vector Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Genetic Virus Vector Market Share by Region (2016-2027)
Figure 39. China Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Genetic Virus Vector Market Share by Type (2016-2027)
Figure 47. Latin America Genetic Virus Vector Market Share by Application (2016-2027)
Figure 48. Latin America Genetic Virus Vector Market Share by Country (2016-2027)
Figure 49. Mexico Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Genetic Virus Vector Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Genetic Virus Vector Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Genetic Virus Vector Market Share by Country (2016-2027)
Figure 55. Turkey Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Genetic Virus Vector Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. FUJIFILM Diosynth Biotechnologies U.S.A. Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 60. Lonza Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 61. Merck KGaA Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 62. GENERAL ELECTRIC COMPANY Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 63. Oxford BioMedica Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 64. Spark Therapeutics, Inc. Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 65. uniQure N.V. Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 66. FinVector Vision Therapies Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 67. Brammer Bio Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 68. Cell and Gene Therapy Catapult Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 69. Cobra Biologics Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 70. REGENXBIO Inc. Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 71. Kaneka Eurogentec S.A. Revenue Growth Rate in Genetic Virus Vector Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed